Despite a significantly subdued start to 2023, M&A volumes in the US healthcare sector are beginning to stabilize and companies are preparing for a wave of M&A in Q3 and Q4, according to RBC Capital.
Tough financing markets and access to capital are impacting the decisions of smaller-mid cap companies – who are examining strategic alternatives including acquisition deals to boost value. Compressed valuations and heightened boardroom CEO confidence across various healthcare subsectors are encouraging increased transaction levels. The need to accelerate top-line growth and drive scale remain key drivers of M&A across various healthcare sectors. Read more.
